Traditional inhalers release medication in particles that don’t always reach deep into the lungs. NanoIn’s nanoaerosol delivery technology produces ultra-fine medication particles designed for optimal penetration into the lower airways.
This increases drug efficiency, reduces waste, and helps patients experience faster relief with lower doses. Paired with AI-driven monitoring, nanoaerosol inhalers represent the next frontier in respiratory treatment.